Clonidine is used to treat high blood pressure by helping blood vessels relax and reducing heart rate. It is also used to help manage ADHD symptoms in children and to reduce hot flashes in menopausal women.[2] Catapres is currently approved and in use across 55 indications[4].[1]
Catapres is one of 926 small molecule programs targeting Cardiovascular Disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
2828 competitors in Breast Cancer
Catapres
Avastin
Prolia
DATROWAY
Cymbalta
Voltaren
MS Contin
Tricor
Cortef
Neoadjuvant Therapy
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
CATAPRES
NDA NDA017407
Oct 10, 1984
CATAPRES-TTS-1
NDA NDA018891
Oct 2, 1996
DURACLON
NDA NDA020615
Sep 30, 2009
JENLOGA
NDA NDA022331
Dec 3, 2009
NEXICLON XR
NDA NDA022500
Dec 3, 2009
CLONIDINE
NDA NDA022499
May 24, 2024
ONYDA XR
NDA NDA217645
Oct 23, 2025
JAVADIN
NDA NDA220256
Sources
Details